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July 14, 2015 payment for the 30-day cycle of PCI care has been proposed as a strategy to reduce hospitalization rates and to improve the value of PCI services. 10 However, the extent to which variation in hospitalization after PCI is related to facilitylevel outcomes and the cost for this cycle of care have not been described.
To inform this aspect of PCI value, we assessed the relationship between facility-level 30-day risk-adjusted hospitalization, mortality, and cost after PCI across the Veterans Affairs (VA) system among a national cohort of patients undergoing PCI in the VA from 2008 to 2012. If 30-day hospitalization rates are closely related to facility-level cost and outcomes, this would further support efforts to reduce rates of hospitalization after PCI to improve value. Alternatively, if cost and outcomes are not related to hospitalization rates after PCI, this would challenge the current focus on PCI readmissions as an effective approach to improving healthcare value.
Methods

Study Setting
The Veterans Health Administration is the largest integrated healthcare delivery system in the United States, caring for nearly 8 million enrollees through its 138 medical centers, 909 outpatient clinics, and 135 community-living centers. 11 The financial management system of the VA (Decision Support System) is an accounting method to track use and costs rather than charges and payments. The Decision Support System uses an "activity-based costing" approach, similar to microcosting, and assigns costs based on relative value units for products of care using automated data. 12 The Decision Support System includes direct costs such as healthcare products and staff time, as well as indirect costs such as overhead, allocated on the basis of specified algorithms. 13 This system is the primary data source that informs VA Health Care operation budgetary requests and serves as the source of cost data for the present analyses. 11, 14 The VA Clinical Assessment, Reporting, and Tracking (CART) Program is the national clinical quality program for all VA cardiac catheterization laboratories. The CART Program uses a software application that is embedded within the VA electronic health record to collect patient and procedural data at the point of care for all cardiac catheterizations and PCIs performed in the VA. [15] [16] [17] These data are linked to the VA electronic health record, allowing linkage to longitudinal data on mortality, hospitalizations, outpatient visits, medications, and laboratory results. In addition, the CART data are linked to billing data from non-VA providers who are reimbursed by the VA for the care of veterans. The validity of CART data has previously been described.
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Patient and Hospital Inclusion Criteria
To avoid inflating variation in clinical and cost outcomes resulting from small numbers, we included only hospitals in our analyses that performed at least 10 PCIs annually from October 1, 2007, through September 30, 2011 . We limited our analyses to the patient's first (index) PCI during this study period. Consistent with the definition of the National Quality Forum-and American College of Cardiologyendorsed PCI readmission measure, index PCI included patients who were admitted to the hospital for their index PCI (inpatients) and patients who underwent PCI without being admitted (outpatient or observation stay). 18 In addition, we excluded staged PCI procedures as defined in previous CART analyses 19 from our assessment of 30-day hospitalization to be consistent with this measure. Healthcare cost included all use during the index hospitalization through 30-days after discharge for the index PCI. These costs included healthcare use in the VA and non-VA facilities paid by the VA (fee-basis program). We attributed all of the healthcare costs, hospitalizations, and mortality to the index hospital in which the PCI occurred. The analysis was approved by the Colorado Multiple Institutional Review Board.
Outcomes
The primary outcome was all-cause hospitalization in the 30 days after discharge from the index PCI. For index PCI performed as a same-day outpatient procedure, the date of the procedure was considered the date of discharge for the index PCI. Hospitalization was ascertained from VA administrative inpatient data records. We reviewed hospitalization International Classification of Diseases, Ninth Revision codes for the primary discharge diagnosis to identify common reasons for hospitalization after the index PCI. The secondary clinical outcome was all-cause mortality occurring in the time period after the PCI procedure through 30 days after discharge for the index PCI. Death was ascertained from the VA Information Resource Center Vital Status File, 20 which compiles data from the Beneficiary Identification Records Locator Subsystem Death File, VA Medicare Vital Status File, and the Social Security Administration Death Master File.
The primary cost outcome was total healthcare cost during the index PCI hospitalization and in the 30 days after discharge from the index procedure obtained from the VA Decision Support System. To account for regional variation in wage and material costs across the VA system, raw costs were scaled by the Medicare wage index. 21 Total cost was broken down into the index procedural cost, defined as all costs accrued during the index PCI hospitalization, and subsequent cost, defined as all costs accrued from discharge through 30 days. Costs for hospitalizations included the full cost of the hospital stay, even when the time period of hospitalization extended beyond 30 days after discharge from the index hospitalization.
Statistical Analysis
All statistical analyses were performed with SAS version 9.4 (SAS Institute Inc, Cary, NC), R version 2.11.1 (May 31, 2010; The R Foundation for Statistical Computing), RStudio (version 0.97.309, RStudio, Inc), and JAGS 3.3.0 (Martyn Plummer). Additional packages required in R included rjags, bayesian graphical models using Markov chain Monte Carlo, and flexsurv, flexible parametric survival models.
We used bayesian hospital profiling methods to estimate standardized mortality, hospitalization, and cost ratios and rates and to identify facility outliers for 30-day risk-standardized mortality, hospitalization, and cost. The model for detecting outliers is more easily implemented in a bayesian framework, has become widely used in profiling hospital performance, and tends to be more conservative (more specific and less sensitive) than other approaches of identifying variation by facility. 22, 23 Risk-standardized outcomes of mortality, hospitalization, and cost ratios were obtained from bayesian Markov chain Monte Carlo implemented in JAGS using standardized covariates with zero mean and unit variance. For risk adjustment, we started with 35 variables, including hospital factors and patient demographics and comorbidities from both the Elixhauser comorbidities and the National Cardiovascular Data Registry risk prediction mortality model. 24, 25 We retained the most significant 24 covariates for our analytical models (Table 1 ) using a single backward elimination for cost with a generalized γ distribution estimated by maximum likelihood. This set of 24 covariates included all 14 covariates that were significant for mortality and all 20 that were significant for hospitalization with the use of mixed logistic regression models.
Risk-standardized mortality, standardized hospitalization, and standardized cost were modeled with Markov chain Monte Carlo with a single chain of 3000 burn-in iterations and 10 000 estimation iterations to obtain a risk-standardized mortality ratio, risk-standardized hospitalization ratio, and risk-standardized cost ratio for each hospital and their associated credibility intervals. 26 Mortality and hospitalization were modeled as logistic regressions. Cost was by guest on May 1, 2017 http://circ.ahajournals.org/ Downloaded from modeled with a generalized γ distribution. 27 All models included hospital random intercepts to account for clustering of patients within hospitals and for use in calculating hospital estimates of riskstandardized ratios. Initial values passed to JAGS for coefficients of the risk adjustment covariates and for parameters of the generalized γ were captured from the output of a maximum likelihood fit with the use of the flexsurv model in R. Initial values for mortality and hospitalization were captured separately from respective logistic regression models in R. To examine hospital-level associations of mortality, hospitalization, and cost, the risk-standardized ratios for each hospital for mortality, hospitalization, and cost outcomes were plotted against each other in scatterplots, and Pearson correlations were estimated.
Subgroup Analyses
In addition to risk-adjusted analyses described above, we repeated our analyses after stratifying on the clinical indication for PCI (ie, PCI for acute coronary syndrome versus elective PCI), given the potential for differences in mortality, readmission, and cost that are predominantly a reflection of the procedural indication. This analysis also afforded an opportunity to assess for facility-level correlation on mortality, readmission, and cost outcomes across indications for PCI.
Sensitivity Analysis
Although our primary analysis includes costs of healthcare use in the VA and non-VA facilities paid by the VA, it does not account for costs of healthcare use attributed to Medicare. To ensure that our findings were robust to potential variation in Veteran dual use of VA and Medicare across facilities, we repeated our analyses after restricting our cohort to patients <65 years of age. Furthermore, to ensure that variation in facility-level readmission, mortality, and cost outcomes was not influenced by the inclusion of small-volume PCI centers, we repeated our analyses after restricting to the 58 hospitals performing at least 100 PCIs during the study period.
Results
Of the 66 VA hospitals that perform PCI, we excluded the 4 hospitals that performed <10 PCIs annually during the study period of 2008 to 2011. The final analytical cohort consisted of 32 080 patients treated at 62 hospitals.
Among the 62 hospitals evaluated, the median annual PCI volume was 111.9 (interquartile range, 86.2-145.8; Table 1 ). Most hospitals (64.5%) had on-site computed tomography surgery backup and were teaching hospitals (85.5%). Among patients undergoing PCI, 64.1% were undergoing elective procedures, and comorbidities were common, including diabetes mellitus (47.3%), obesity (32.5%), chronic pulmonary disease (28.7%), congestive heart failure (24.3%), and peripheral arterial disease (23.8%; Table 1) .
At the hospital level, the 30-day unadjusted median mortality rate after PCI was 1.5% (interquartile range, 1.0%-2.5%). Point estimates for facility risk-standardized mortality ratios ranged from 0.74 to 1.56, none of which were significantly different from the risk-standardized median mortality rate.
The facility-level unadjusted median 30-day hospitalization rate was 10.8% (interquartile range, 8.8%-12.2%). The most common discharge diagnoses for hospitalization after the index PCI are shown in Table 2 . Facility-level risk-standardized hospitalization ratios varied significantly from 0.82 (95% credibility interval, 0.66-0.98) to 1.24 (95% credibility interval, 1.06-1.45). A total of 4 hospitals (6.4%) had a riskstandardized hospitalization rate that differed significantly 4%) with significantly lower-than-expected costs, ranging to a low of 56.0% below the median (95% credibility interval, 63.2-47.2 below the median), and 14 (22.6%) hospitals with significantly higher-than-expected costs, ranging to 130.8% above the median (95% credibility interval, 82.8-199.2 above the median). At the facility level, the proportion of total cost accounted for by the index hospitalization ranged from 60.3% to 92.2% (median, 83.1%), with the proportion of total cost related to hospitalization in the 30 days after PCI ranging from 2.0% to 12.7% (median, 5.8%; Figure 1 ).
We plotted hospital-standardized mortality ratios, standardized hospitalization ratios, and standardized total cost ratios by ascending order of hospital total cost ratio ( Figure 2 ). There was no correlation between hospital standardized total cost and hospital-standardized mortality (Spearman ρ=−0.15; 95% confidence interval, −0.38 to 0.11; P=0.25). Similarly, hospital-standardized cost and hospitalization rates were not statistically significantly correlated (Spearman ρ=0.16; 95% confidence interval, −0.09 to 0.39; P=0.21).
In subgroup analyses of patients with acute coronary syndrome as the indication for PCI, we identified no facility-level outliers for mortality or readmission. In contrast, 27 hospitals (43.5%) were outliers for 30-day total cost (see Figure  I in the online-only Data Supplement). In patients receiving elective PCI, we observed 1 facility outlier for 30-day mortality, no outliers for readmission, and 20 facility outliers 
Discussion
In this study of >32 000 patients undergoing PCI across 62 VA hospitals nationally, we assessed facility-level mortality, hospitalization, and costs of care in the 30 days after PCI to inform variation in healthcare value. There was no significant variation in 30-day mortality after PCI. In contrast, there were variability in 30-day hospitalization rates and even greater variation in 30-day total cost. Costs attributable to hospitalization after PCI represented <6% of the total cost, and variations in facility-level cost were not clearly correlated with hospitalization rates. In contrast, costs of the index PCI accounted for >80% of the total cost, and significant variations in the costs of the index hospitalization were observed. These findings have important implications for measuring the value of PCI care delivery and may inform strategies of healthcare reimbursement to incentivize improvements in healthcare value. Furthermore, these findings suggest an opportunity to reduce variation in the total cost of PCI without compromising patient outcomes to achieve high-value care delivery.
Proponents of a value framework for improvement in healthcare delivery suggest that outcomes and costs of care should be measured for specific medical conditions over the entire cycle of care delivery. [1] [2] [3] [4] In earlier work, we demonstrated variation in 1-year value after PCI in the VA resulting from significant variation in facility-level total costs despite 28 These previous findings speak to variation in the value of longitudinal care in the year after PCI. In the present analysis, we evaluated the 30-day period after PCI, given the emphasis on short-term outcomes as reflecting the cycle of PCI care attributable to the hospital where the index PCI was performed.
Overall, patients in the VA achieved good 30-day PCI outcomes, as evidenced by relatively low mean 30-day mortality (1.8%) and hospitalization rates (11.2%) compared with rates for 30-day mortality (2.9%) 25 and hospitalization rates (14.6%) 7 in the Medicare population. Although mortality rates by facility did not vary in the VA, healthcare costs varied significantly. These variations in costs suggest that there are significant differences in processes and structures of care during the index procedure and in the 30 days after PCI that contribute to variation in value. Furthermore, the strong facility-level correlation between standardized hospital costs for patients with acute coronary syndrome and elective PCI suggests that the processes contributing to variation in costs of PCI care were consistent across a range of clinical scenarios. It should be noted that we estimated actual costs from the internal accounting system of the VA rather than prices, which are often used in studies based on claims data.
Our findings agree with a previous VA study that used a statistical model to demonstrate variation in efficiency of care, with the least efficient hospitals having nearly 28% higher risk-adjusted costs than the most efficient VA hospitals. 11 Similarly, a recent study found significant variation in the use of cardiac procedures between fee-for-service Medicare and Medicare Advantage beneficiaries despite similar outcomes. 29 Together, these findings suggest that suboptimal healthcare value is not simply a function-integrated versus fee-for-service care delivery. 30 Lessons learned in measuring and achieving optimal healthcare value in settings like the VA may inform emerging accountable care organizations as they seek to achieve better quality and outcomes at lower costs. Our study challenges the focus on hospitalizations after PCI as a means of improving healthcare value. In light of the high and variable rate of hospitalization after PCI noted in previous studies, reducing hospitalizations has been targeted as a quality measure. 31 It is hoped that better patient outcomes may be achieved by reducing preventable hospitalizations while reducing costs of care. However, the extent to which these hospitalizations are avoidable may be small. 32, 33 Furthermore, the primary factors that contribute to hospitalization rates may relate to factors that are not in the control of the hospital, including the composition of the patient population of the hospital and the presence or absence of community resources after discharge. 34, 35 Finally, some studies have suggested that improved coordination and access to care may increase hospitalization rates, while concurrently improving patient satisfaction. 36 Thus, emphasis on reducing hospitalization rates alone may result in lower value, as reflected by worse patientcentered outcomes. The present analysis adds to concerns that emphasizing hospitalization rates after PCI may not be an ideal target for improving healthcare value, given that facilitylevel variation in hospitalization rates after PCI was modest, hospitalizations after PCI were a small component of facilitylevel 30-day total cost, and facility-level hospitalization rates were not clearly related to variation in facility-level 30-day total cost.
As the measurement of cost and outcomes becomes increasingly adopted in a value framework, bundled payment for care delivery has been proposed to incentivize high-value care. 10 In the reimbursement of PCI care, bundled payment could be limited to the PCI hospitalization, or it could also cover all care provided through 30 days after discharge. Arguments against the inclusion of postdischarge care in payment bundles include the challenges of attribution of postdischarge care to hospitals, nonmodifiable causes of subsequent hospitalization, and the potential disincentive to necessary follow-up care. [32] [33] [34] [35] [36] [37] [38] In contrast, bundled payments that include postdischarge care may incentivize greater integration of care across inpatient and postdischarge settings. 39, 40 The present analysis highlights the large contribution and variation in the cost of the index hospitalization and the potential for focus on the index hospitalization to spur efforts to improve PCI value. Previous studies of VA care have demonstrated simultaneous declines in hospital length of stay and readmission rates, 41 suggesting that efforts to reduce costs associated with the index hospitalization may not be offset by higher postdischarge costs.
Our study should be considered in light of the following limitations. First, because this was an observational study, we cannot exclude unmeasured confounding. However, we conducted robust risk adjustment using conservative methods for the identification of hospital outliers with regard to mortality, hospitalization, and cost outcomes. Furthermore, because the intent of the study was to jointly evaluate variation in patient outcomes and cost in routine clinical practice, an observational study design is the only feasible approach. Second, there is the potential for variation in attributing specific costs to a cost center across VA medical centers. 42 However, total costs should not be influenced by variation in attribution to cost centers because the VA has a national costing system. In addition, we have previously demonstrated a strong correlation (r=0.87) between use and costs. 28 This correlation suggests that variability in total cost cannot be attributed solely to differences in costing methods across sites. Third, our analysis is from the perspective of the VA system and did not include costs for care outside the VA healthcare system that were not paid for by the VA, including Medicare costs for Veterans dually eligible for VA and Medicare. However, our sensitivity analysis restricted to patients <65 years old who are not eligible for Medicare was consistent with the findings of our primary analysis.
Furthermore, the index PCI comprised the predominant cost in this analysis, and this cost is not influenced by variation in dual use of VA and other insurance sources. Fourth, the VA accounting system used for the present analysis may not be directly applicable to other healthcare systems or payers and may limit generalizability. However, the within-system comparison of the present study highlights opportunities for improving healthcare care value within integrated and salaried care delivery like the VA. This is particularly relevant given the push toward accountable care organizations that will be responsible for the quality, outcomes, and costs of care for a population of patients. Finally, our analysis makes an implicit assumption that the PCI under study was necessary because we are unable to assess the appropriateness of PCI performed in the VA from available data. Future studies are needed to determine the patient health benefit and healthcare value derived from the procedure under study, rather than assuming that the procedure was performed for an appropriate indication.
Conclusions
We assessed variation in healthcare value as represented by mortality, hospitalization, and cost in the 30 days after PCI at VA hospitals. We observed no variation in facility-level 30-day PCI mortality despite a large variation in cost. Although facility-level hospitalization rates after PCI varied, hospitalization accounted for only 6% of 30-day cost and was not clearly related to facility-level costs, suggesting that an emphasis on hospitalizations after PCI may not result in large improvements in healthcare value. Instead, our findings suggest an opportunity to address variation in the total cost of PCI care without compromising patient outcomes to achieve high-value care delivery. Our approach to value assessment may inform healthcare systems and accountable care organizations seeking to optimize patient outcomes while minimizing costs of care. 
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